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Introduction 
Giant lymph node hyperplasia (GLNH) was first 
described by Castleman in 1954 (1). It is known to 
produce a wide variety of clinical, laboratory and 
radiological features but it commonly presents 
asymptomatically as in this case. The Medical litera- 
ture has infrequent references to Castleman’s disease 
which is rare in children. 
Case Report 
This lo-year-old Caucasian presented to our Out- 
patient department with a history of having been 
pushed, kicked and jumped upon whilst playing at 
school! He did not appear to be in any kind of 
distress. On clinical examination, apart from the 
mild tenderness over the third rib on the left side, 
there was nothing else of note. A routine chest 
X-ray was arranged to rule out any possible rib 
fracture. To our surprise, it revealed a large 
rounded mass lesion lying to the right side of the 
mediastinum (Plate 1). The lung fields were clear 
and heart outline was normal. The CT scan of the 
thorax (Plate 2) confirmed the presence of the mass 
in the anterior mediastinum measuring 37 mm in 
diameter. It was found to be solid in consistency 
and enhanced considerably with omnipaque con- 
trast medium. The results of other investigations 
including full blood count, serum immunoglobulin 
levels, serum alpha feto protein level and urinary 
catecholamines were normal. 
Thoracotomy was performed and the mass was 
excised. Post operation recovery was rapid and the 
boy has remained asymptomatic. The histological 
diagnosis was Castelman’s disease of the hyaline 
vascular type. 
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Diiussion 
Clinical presentation of GLNH can be varied. 
Many patients can present with asymptomatic medi- 
astinal mass, usually discovered on routine chest 
radiographs, as in our case. Occasionally symptoms 
referable to tracheobronchial compression are 
present. The enlarged nodes may also be present in 
the neck, axilla or abdomen (2). 
Other clinical manifestation which has been 
observed is anaemia, with features similar to an iron 
deficiency state but not responding to iron therapy 
(3). Fever, and/or weight loss are associated with 
this type of presentation. Elevated ESR, thrombo- 
cytosis and hypergammaglobulins are other associ- 
ated abnormal laboratory results that have been 
reported (4). 
Unusual clinical features reported in the litera- 
ture (5) include amyloidosis, nephrotic syndrome, 
thrombocytopenia, thrombotic thrombocytopenic 
purpura, myasthenia gravis, peripheral neuropathy, 
erosive stomatatis with keratitis and mylefibrosis. 
Most of these have been associated with mesenteric 
or retroperitonial lymphadenitis. Symptoms tend to 
resolve when abnormal lymph nodes are restricted 
(6). Ultrasound examination reveals a mixed mass 
that mimics findings in a node involved in a 
lymphomatous process. 
Radiologically the intrathoracic form appears as a 
rounded mediastinal or hilar mass with well-defined 
margins. The hyaline vascular form has been 
observed to enhance well with contrast computed 
tomography due to increased vascularity. This has 
also been noted in angiographic studies (7). This calls 
for cautious surgical approach due to the potential of 
bleeding. 
Histologically two main types have been 
reported. The hyaline vascular type characterized 
microscopically by prominent vascular proliferation 
and hyalinization. The plasma cell type is character- 
ized by sheets of mature plasma cells in the 
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Plate I Chest X-ray revealing a mediastinal mass on the right side. 
Plate 2 CT scan showing the mass in the anterior mediastinum on the right side. 
interfollicular spaces and exhibit much less vascular Management of Castleman’s disease requires sur- 
proliferation. In some of the hyaline vascular gical removal of the lesion. This is both diagnostic as 
lesions, small areas exhibiting features of the well as therapeutic. Complete excision should be the 
plasma cell type may be seen (2). Plasma cell type aim but if attached to vital structures, portions of 
seems to account for the majority of symptomatic node can be left behind. In children no recurrences 
cases. have been reported. Radiation treatment (8) and 
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chemotherapy have been tried in adult patients but 2. 
with limited success. 
The clinical and pathological spectrum of GLNH 
is expanding and should be included in the differen- 3, 
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